A few years ago, Microsoft made a move that most people never noticed.
There was no big product launch, no headline-grabbing acquisition, and nothing that would have caught the attention of the broader market. Instead, they expanded quietly through a series of licensing agreements tied to cloud infrastructure, artificial intelligence capabilities, and enterprise integrations. These deals didn’t generate buzz, but they did something far more important—they allowed Microsoft to accelerate growth, expand functionality, and reduce development timelines without having to build everything internally.
At the same time, Qualcomm continues to generate billions of dollars every year through licensing its patent portfolio across mobile devices worldwide, while companies like Medtronic and Johnson & Johnson consistently look outside their organizations to license early-stage technologies that can strengthen their product pipelines and maintain their competitive edge.
When you step back and look at these examples together, something becomes very clear.
These companies are not relying solely on internal innovation to grow. They are using licensing as a strategic tool to expand faster, reduce risk, and access new opportunities that would take significantly longer to build on their own.
And once you begin to see licensing through that lens, it changes how you think about your own intellectual property.
Licensing Is Not About Having Good IP—It Is About Business Fit
One of the most common misconceptions I see is the belief that strong intellectual property naturally leads to licensing opportunities.
It doesn’t.
Companies do not license IP because it is interesting or innovative on its own. They license it because it fits into something they are already trying to accomplish, whether that is launching a new product, improving an existing one, entering a new market, or solving a problem that already exists within their business.
If you look at Qualcomm’s model, their success is not based on simply having valuable patents. Their patents are embedded in communication standards that manufacturers depend on, which means their IP is directly tied to the functionality of the products being built. That creates a natural alignment between the IP and the needs of the licensee.
Now compare that to most independent IP owners.
Even when the invention is strong, the conversation often stalls because the connection to the licensee’s business is not clearly defined. The question that every company is asking, whether they say it directly or not, is simple: how does this fit into what we are already doing?
If that answer is not clear, the opportunity becomes difficult to justify.
That is why licensing starts with positioning. Not outreach, not negotiation, but positioning your IP in a way that aligns with real business objectives.
The Structure of the Deal Determines What Actually Happens
When you look at real-world licensing agreements, especially in industries like pharmaceuticals and biotechnology, you will notice that deals are rarely built around a single number.
Instead, they are structured in layers, often combining upfront payments, milestone-based incentives, and ongoing royalties that reflect the commercial success of the product.
That structure exists for a reason.
It aligns incentives between both parties while managing risk over time, ensuring that the licensee is not overcommitting too early and that the licensor participates in the upside as progress is made.
When you apply that thinking to your own situation, it shifts your focus away from simply asking what royalty rate you should expect and toward understanding how the agreement will function in practice.
You begin to look at how performance will be measured, what happens if timelines slip, and how progress is maintained throughout the lifecycle of the deal.
Because in the end, the structure of the agreement is what determines whether your IP moves forward or sits idle.
Exclusivity Should Be Designed, Not Given Away
Exclusivity is another area where real-world deals offer important insight.
In many licensing agreements, exclusivity is not absolute. It is carefully defined by territory, product category, or specific application, allowing the licensee to commit resources while still preserving opportunities for the licensor.
The reason exclusivity matters is because it drives behavior.
When a company knows it has protected access to a particular opportunity, it is far more likely to invest in development, marketing, and commercialization. But that same protection can also limit your flexibility if the licensee does not perform as expected.
This is where many IP owners make avoidable mistakes, either offering exclusivity too broadly or avoiding it altogether without understanding how it can be used strategically.
The right approach is not about saying yes or no to exclusivity, but about structuring it in a way that creates commitment while still protecting your long-term options.
Royalty Rates Reflect Value, Not Just Industry Norms
Another area where real deals provide clarity is in how royalty rates are determined.
It is tempting to look for standard percentages or industry averages and assume that those numbers apply across the board, but in practice, royalty rates are shaped by context.
They depend on how central your IP is to the final product, how much development work is still required, and how the economics of the licensee’s business operate.
In high-volume, lower-margin industries, royalty rates may be lower but generate significant revenue through scale. In more specialized or technical applications, higher rates may be justified because the IP plays a critical role in the product’s performance or differentiation.
This is why the question is not simply what is typical, but what is appropriate based on the value your IP creates within a specific commercial framework.
Finding the Right Licensee Is Where Most Deals Begin to Take Shape
If there is one area where most licensing efforts break down, it is in targeting.
Companies like Microsoft, Medtronic, and Johnson & Johnson are not evaluating opportunities randomly. They are focused on very specific priorities that align with their strategic direction, and any opportunity that does not connect to those priorities is unlikely to move forward.
This means that licensing is not about reaching out to as many companies as possible.
It is about identifying the right companies, understanding where your IP fits within their business, and approaching the right decision-makers with a message that speaks directly to their needs.
When that alignment exists, conversations happen naturally.
When it does not, even strong intellectual property can struggle to gain traction.
The Details in the Agreement Shape the Outcome
One of the more subtle lessons from real licensing deals is how much impact the details of the agreement have over time.
It is not always the headline terms that create problems, but the areas that are left undefined or loosely structured, such as performance expectations, reporting requirements, or termination conditions.
These elements may not seem critical during negotiation, but they often determine how the relationship evolves once the agreement is in place.
Without clear expectations and accountability, it becomes difficult to ensure progress, measure performance, or regain control if the licensee does not follow through.
This is why the quality of the agreement matters just as much as the fact that a deal was signed.
Licensing Is a System, Not a Single Event
When you step back and look at how the largest companies approach licensing, a consistent pattern emerges.
They are not treating licensing as a one-time opportunity.
They are treating it as a system.
Strategy leads to positioning.
Positioning informs targeting.
Targeting drives outreach.
Outreach leads to negotiation.
And negotiation defines the long-term value of the deal.
Each step builds on the one before it, and when the system is aligned, the results follow.
Where We Fit In
At Licensing Consulting Group, this is exactly how we approach licensing.
We focus on the entire process, from evaluating your intellectual property and defining its commercial potential to developing a strategy, identifying the right opportunities, managing outreach, and supporting negotiations through to execution and beyond.
Because licensing, when approached correctly, is not just about getting a deal done.
It is about building a structured approach that creates real, repeatable opportunities.
Let’s Talk About Your IP
If you are thinking about licensing your IP, or you are already exploring opportunities and want to make sure you are approaching it the right way, the best place to start is with a focused conversation.
Every situation is different, and understanding the right path forward depends on your IP, your market, and your goals.
You can schedule a short strategy call here:
👉 https://calendly.com/licensingcg/15-minute-video-meeting
Stay Ahead of What Is Changing
The licensing market continues to evolve, and the companies that succeed are the ones that understand how to adapt to those changes and position their IP accordingly.
If you want to stay informed with practical insights, real-world strategies, and ongoing guidance, you can also sign up for the LCG newsletter:
👉 https://licensingconsultinggroup.com/newsletter/
Rand Brenner is an IP professional whose passion is helping inventors, startups, and businesses use licensing to turn their IP into income-producing products, services, and technologies. His decades of experience run the gamut from medical devices to food technology to consumer products. He’s licensed some of the biggest Hollywood entertainment blockbusters, including the Batman Movies (1 and 2) and the number one kid’s action TV show, the Mighty Morphin Power Rangers. Rand speaks about licensing and is a featured speaker at investment conferences, trade shows, colleges, and startup events. His first book, Hidden Wealth: The Money-Making Power of Licensing, was released in 2019 and is available on Amazon.com. He’s also a published writer, and his articles have appeared in several prestigious trade magazines, including The Licensing Journal, Intellectual Property Magazine, and License India.
Working Through a Licensing or Commercialization Challenge?
If you have market-ready intellectual property, a licensing campaign that has stalled, or a business opportunity that may benefit from licensing, a short strategy discussion can help clarify the next step.